JAGX Jaguar Health, Inc.
Healthcare$3.11+6.87%ClosedMarket Cap: $207,250
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.11
P/S
0.01
EV/EBITDA
-0.80
DCF Value
$-23,156.44
FCF Yield
-3928.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
85.1%
Operating Margin
-86.3%
Net Margin
-115.4%
ROE
764.5%
ROA
-91.1%
ROIC
-133.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $20.3M | 94.3% | $10.2M | $8.8M | $— | — |
| Q4 null | $3.2M | 32.0% | $-20.4M | $-23.1M | $— | — |
| FY null | $11.5M | 67.2% | $-45.9M | $-53.6M | $— | — |
| Q3 null | $3.1M | 82.7% | $-7.2M | $-9.5M | $— | — |
| Q2 null | $3.0M | 82.3% | $-8.0M | $-10.4M | $— | — |
| Q1 null | $2.2M | 76.7% | $-9.4M | $-10.5M | $— | — |
| Q4 null | $3.5M | 84.1% | $-8.2M | $-9.9M | $— | — |
| FY null | $11.7M | 83.3% | $-30.8M | $-38.5M | $— | — |
| Q3 null | $3.1M | 82.6% | $-7.3M | $-9.9M | $— | — |
| Q2 null | $2.7M | 84.3% | $-7.2M | $-9.5M | $— | — |
| Q1 null | $2.4M | 81.7% | $-8.2M | $-9.2M | $— | — |
| Q4 2023 | $2.3M | 70.1% | $-7.6M | $-9.2M | $-600.00 | — |